Unnamed: 0,title,date,stock,sentiment
1002876.0,"Oppenheimer Maintains Outperform on Pfenex, Raises Price Target to $10",2020-06-01 11:52:00-04:00,PFNX,neutral
1002877.0,"SunTrust Robinson Humphrey Maintains Buy on Pfenex, Lowers Price Target to $13",2020-05-12 09:23:00-04:00,PFNX,negative
1002878.0,"Pfenex Q1 EPS $(0.310) Misses $(0.240) Estimate, Sales $682.000K Down From $7.862M YoY",2020-05-07 16:57:00-04:00,PFNX,negative
1002879.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,PFNX,negative
1002880.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,PFNX,neutral
1002881.0,"Oppenheimer Initiates Coverage On Pfenex with Outperform Rating, Announces Price Target to $9",2020-04-23 06:27:00-04:00,PFNX,neutral
1002882.0,70 Biggest Movers From Yesterday,2020-04-16 04:38:00-04:00,PFNX,neutral
1002883.0,Mid-Afternoon Market Update: Dow Falls 1.5%; Pfenex Shares Plummet,2020-04-15 14:37:00-04:00,PFNX,positive
1002884.0,50 Stocks Moving In Wednesday's Mid-Day Session,2020-04-15 12:35:00-04:00,PFNX,neutral
1002885.0,Mid-Day Market Update: Crude Oil Down 3%; Applied DNA Sciences Shares Jump,2020-04-15 12:01:00-04:00,PFNX,negative
1002886.0,Morning Market Stats in 5 Minutes,2020-04-15 10:10:00-04:00,PFNX,neutral
1002887.0,"The Daily Biotech Pulse: Applied DNA Ships Vaccine Constructs For Animal Testing, Herceptin Biosimilar Now Available In US",2020-04-15 08:03:00-04:00,PFNX,neutral
1002888.0,Pfenex Reports FDA Has Requested Added Comparative Use Human Factors Data In Order To Complete PF708 Determination,2020-04-14 17:06:00-04:00,PFNX,positive
1002889.0,"Pfenex FY19 EPS $0.03 Up From $(1.4) YoY, Sales $50.326M Up From $14.857M YoY",2020-03-11 16:16:00-04:00,PFNX,neutral
1002890.0,"The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment",2020-03-11 08:03:00-04:00,PFNX,positive
1002891.0,"Earnings Scheduled For March 11, 2020",2020-03-11 04:28:00-04:00,PFNX,neutral
1002892.0,"The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues",2020-03-08 16:14:00-04:00,PFNX,negative
1002893.0,"SunTrust Robinson Humphrey Initiates Coverage On Pfenex with Buy Rating, Announces $18 Price Target",2020-02-14 08:44:00-05:00,PFNX,neutral
1002894.0,44 Stocks Moving in Thursday's Pre-Market Session,2020-02-06 07:26:00-05:00,PFNX,neutral
1002895.0,82 Biggest Movers From Yesterday,2020-01-22 04:18:00-05:00,PFNX,neutral
1002896.0,Pfenex Earns $15M Development Milestone Under Its Development And License Agreement With Jazz Pharmaceuticals,2019-12-18 08:10:00-05:00,PFNX,positive
1002897.0,"The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing",2019-11-14 08:07:00-05:00,PFNX,positive
1002898.0,Pfenex Reports CFO Susan Knudson Resigned; Co. Conducting Search For Successor,2019-11-13 16:40:00-05:00,PFNX,neutral
1002899.0,"Pfenex Q3 EPS $0.09 Beats $(0.04) Estimate, Sales $15.248M Beat $9.57M Estimate",2019-11-07 16:07:00-05:00,PFNX,neutral
1002900.0,"The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOs",2019-11-07 07:18:00-05:00,PFNX,negative
1002901.0,"The Week Ahead In Biotech: Smid-Cap Earnings Deluge, SITC Conference In The Spotlight",2019-11-03 10:51:00-05:00,PFNX,neutral
1002902.0,"Cantor Fitzgerald Initiates Coverage On Pfenex with Overweight Rating, Announces $20 Price Target",2019-10-25 07:06:00-04:00,PFNX,negative
1002903.0,"The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings",2019-10-13 16:33:00-04:00,PFNX,neutral
1002904.0,"Pfenex Offers Update For PF708 Outside US: Highlights Exclusive Commercialization Deals In South Korea, Canada, Israel, Submitted Marketing Authorization App In Saudi Arabia",2019-10-11 08:06:00-04:00,PFNX,positive
1002905.0,38 Biggest Movers From Yesterday,2019-10-08 05:39:00-04:00,PFNX,neutral
1002906.0,30 Stocks Moving In Monday's Mid-Day Session,2019-10-07 12:32:00-04:00,PFNX,neutral
1002907.0,Pfenex Gets FDA Seal of Approval For Amgen's Forteo Biosimilar,2019-10-07 10:36:00-04:00,PFNX,positive
1002908.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Monday, October 7, 2019",2019-10-07 09:32:00-04:00,PFNX,positive
1002909.0,Pfenex shares are trading higher after the company announced it received an FDA approval for its PF708 to treat Osteoporosis.,2019-10-07 08:38:00-04:00,PFNX,positive
1002910.0,24 Stocks Moving in Monday's Pre-Market Session,2019-10-07 07:49:00-04:00,PFNX,neutral
1002911.0,A Peek Into The Markets: US Stock Futures Down; Crude Oil Rises 1%,2019-10-07 07:24:00-04:00,PFNX,negative
1002912.0,Pfenex Receives U.S. FDA Approval for PF708 to Treat Osteoporosis,2019-10-07 07:07:00-04:00,PFNX,positive
1002913.0,45 Biggest Movers From Friday,2019-10-07 06:11:00-04:00,PFNX,neutral
1002914.0,"The Week Ahead In Biotech: Pfenex And Clinuvel On The Radar Ahead of FDA Decisions, 2 IPOs On Deck",2019-10-06 17:15:00-04:00,PFNX,neutral
1002915.0,34 Stocks Moving In Friday's Mid-Day Session,2019-10-04 12:43:00-04:00,PFNX,neutral
1002916.0,Biotech Stock On The Radar: FDA Verdict Ahead For Pfenex's Osteoporosis Biosimilar,2019-10-03 15:49:00-04:00,PFNX,positive
1002917.0,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,2019-09-30 16:32:00-04:00,PFNX,neutral
1002918.0,"JMP Securities Maintains Market Outperform on Pfenex, Raises Price Target to $17",2019-09-11 07:00:00-04:00,PFNX,positive
1002919.0,"The Daily Biotech Pulse: Translate Bio Halts mRNA Therapy Trial, Roche Multiple Sclerosis Biomarker Data, D-Day For Xeris",2019-09-10 07:36:00-04:00,PFNX,neutral
1002920.0,64 Biggest Movers From Friday,2019-09-09 05:43:00-04:00,PFNX,neutral
1002921.0,"The Daily Biotech Pulse: European Nod For Roche, Takeda Recall, Neon Exults On Journal Publication",2019-09-06 07:27:00-04:00,PFNX,neutral
1002922.0,Pfenex Wins $11M Development Milestone Under Deal With Jazz Pharma,2019-09-05 16:28:00-04:00,PFNX,positive
1002923.0,76 Biggest Movers From Yesterday,2019-08-13 04:57:00-04:00,PFNX,neutral
1002924.0,"Pfenex Q2 EPS $(0.24) Beats $(0.31) Estimate, Sales $2.811M Miss $4.07M Estimate",2019-08-08 16:55:00-04:00,PFNX,negative
1002925.0,"Pfenex And Arcellx Announce A Development, Evaluation And License Agreement",2019-08-01 09:02:00-04:00,PFNX,positive
1002926.0,50 Biggest Movers From Yesterday,2019-07-11 05:19:00-04:00,PFNX,neutral
1002927.0,40 Stocks Moving In Wednesday's Mid-Day Session,2019-07-10 12:17:00-04:00,PFNX,neutral
1002928.0,60 Biggest Movers From Friday,2019-07-01 05:01:00-04:00,PFNX,neutral
1002929.0,"Pfenex, Alvogen Report EMA Accepted Marketing Authorization Application For PF708",2019-05-30 08:05:00-04:00,PFNX,positive
1002930.0,"Pfenex Q1 EPS $(0.12) Beats $(0.26) Estimate, Sales $10.362M Beat $4.06M Estimate",2019-05-09 16:41:00-04:00,PFNX,neutral
1002931.0,"The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stocks To Debut",2019-05-09 07:56:00-04:00,PFNX,neutral
1002932.0,"Pfenex 8-K Shows Co. Received Notice From Dept. Of Health And Human Services BARDA Advising Of Decision Not To Exercise Development Options For cGMP Manufacturing, Potential Phase 1/2b Study For Px563L, RPA563",2019-04-01 16:54:00-04:00,PFNX,neutral
1002933.0,Pfenex To Participate At William Blair Late-Stage Therapeutics Conference Apr. 4,2019-03-27 16:14:00-04:00,PFNX,neutral
1002934.0,52 Biggest Movers From Yesterday,2019-03-21 04:59:00-04:00,PFNX,neutral
1002935.0,Pfenex To Present At 29th Annual Oppenheimer & Co. Healthcare Conference,2019-03-18 16:35:00-04:00,PFNX,neutral
1002936.0,"The Daily Biotech Pulse: Zafgen Won't File IND For Metabolic Disorder Drug, Positive Results For Akebia's Anemia Drug",2019-03-12 07:47:00-04:00,PFNX,positive
1002937.0,Pfenex shares are trading lower after the company reported lower-than-expected Q4 sales results.,2019-03-11 16:45:00-04:00,PFNX,neutral
1002938.0,"Pfenex Q4 EPS $(0.22) Beats $(0.35) Estimate, Sales $3.351M Miss $4.4M Estimate",2019-03-11 16:13:00-04:00,PFNX,negative
1002939.0,Q4 Earnings Outlook For Pfenex,2019-03-11 07:57:00-04:00,PFNX,neutral
1002940.0,"Earnings Scheduled For March 11, 2019",2019-03-11 04:17:00-04:00,PFNX,neutral
1002941.0,"Daily Biotech Pulse: Allergan's Depression Drug Flunks Late-Stage Trial, Apellis Offering, ShockWave Medical IPO",2019-03-07 07:48:00-05:00,PFNX,negative
1002942.0,"Pfenex Reports Licensee, Serum Institute Of India Private, Completed Pivotal Phase 3 Study For Pneumoisl; Primary, Secondary Objectives Were Met",2019-03-06 16:33:00-05:00,PFNX,neutral
1002943.0,81 Biggest Movers From Friday,2019-03-04 05:39:00-05:00,PFNX,neutral
1002944.0,"Pfenex And Alvogen Earlier Announced Agreement o Expand Development And Commercialization Collaboration For PF708, A Therapeutic Equivalent Candidate To Forteo/Forsteo, To The EU, MENA And ROW",2019-02-28 09:34:00-05:00,PFNX,positive
1002945.0,Pfenex Announces FDA Acceptance Of NDA For PF708,2019-02-19 08:13:00-05:00,PFNX,positive
1002946.0,Pfenex Reports FDA Acceptance Of Its New Drug Application For PF708,2019-02-19 08:05:00-05:00,PFNX,positive
1002947.0,46 Biggest Movers From Yesterday,2018-12-11 05:15:00-05:00,PFNX,neutral
1002948.0,Pfenex Submits New Drug Application To U.S. FDA Seeking Approval Of PF708 For The Treatment Of Osteoporosis,2018-12-10 08:10:00-05:00,PFNX,positive
1002949.0,Pfenex Submits New Drug Application to US FDA Seeking Approval of PF708 for the Treatment of Osteoporosis,2018-12-10 08:00:00-05:00,PFNX,positive
1002950.0,48 Biggest Movers From Yesterday,2018-11-30 05:39:00-05:00,PFNX,neutral
1002951.0,41 Biggest Movers From Yesterday,2018-11-27 05:08:00-05:00,PFNX,neutral
1002952.0,"Pfenex Q3 EPS $(0.34), Inline, Sales $3.57M Miss $4.4M Estimate",2018-11-07 17:08:00-05:00,PFNX,negative
1002953.0,"The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie",2018-11-07 07:50:00-05:00,PFNX,negative
1002954.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-04 13:35:00-05:00,PFNX,neutral
1002955.0,76 Biggest Movers From Yesterday,2018-11-02 06:12:00-04:00,PFNX,neutral
1002956.0,Pfenex Names Shawn Scranton COO,2018-09-11 08:06:00-04:00,PFNX,neutral
1002957.0,"The Daily Biotech Pulse: Aveo Slips On Stock Offering, FDA Greenlights Generic EpiPen, Pfenex Exec Resigns",2018-08-17 08:15:00-04:00,PFNX,negative
1002958.0,Pfenex Announces Chief Medical Officer Hubert Chen To Resign Effective September 2nd,2018-08-16 16:11:00-04:00,PFNX,positive
1002959.0,"Pfenex Inc. Common Stock Q2 EPS $(0.41) Misses $(0.36) Estimate, Sales $4.19M Beat $4M Estimate",2018-08-08 17:02:00-04:00,PFNX,negative
1002960.0,"The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings, Paratek Awaits Adcom Verdict",2018-08-08 08:15:00-04:00,PFNX,positive
1002961.0,38 Biggest Movers From Friday,2018-07-16 04:47:00-04:00,PFNX,neutral
1002962.0,"Pfenex Receives Milestone From Merck Associated With Clinical Advancement of Investigational 15-valent Pneumococcal Vaccine PCV-15, Specific Financial Terms Not Disclosed",2018-07-12 08:02:00-04:00,PFNX,neutral
1002963.0,Pfenex to Join Russell 2000,2018-06-22 17:05:00-04:00,PFNX,positive
1002964.0,"Benzinga's Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis Candidate",2018-06-12 08:47:00-04:00,PFNX,positive
1002965.0,7 Stocks Moving In Monday's After-Hours Session,2018-06-11 17:20:00-04:00,PFNX,neutral
1002966.0,"Pfenex, Alvogen Report US Deal For Commercialization Of PF708 In US",2018-06-11 16:06:00-04:00,PFNX,neutral
1002967.0,38 Biggest Movers From Yesterday,2018-05-24 04:44:00-04:00,PFNX,neutral
1002968.0,Mid-Afternoon Market Update: Tiffany Rises Following Q1 Beat; Red Robin Shares Plummet,2018-05-23 14:32:00-04:00,PFNX,positive
1002969.0,33 Stocks Moving In Wednesday's Mid-Day Session,2018-05-23 12:53:00-04:00,PFNX,neutral
1002970.0,Mid-Day Market Update: Dow Falls Over 100 Points; Cara Therapeutics Shares Spike Higher,2018-05-23 12:16:00-04:00,PFNX,positive
1002971.0,Mid-Morning Market Update: Markets Open Lower; Target Earnings Miss Views,2018-05-23 10:45:00-04:00,PFNX,negative
1002972.0,Pfenex Shares Down 15.8% After Co. Earlier Priced 6.8M Share Offering At $5.50/Share,2018-05-23 09:33:00-04:00,PFNX,positive
1002973.0,Pfenex Prices 6.8M Share Offering At $5.50/Share,2018-05-23 09:10:00-04:00,PFNX,positive
1002974.0,20 Stocks Moving In Wednesday's Pre-Market Session,2018-05-23 08:36:00-04:00,PFNX,neutral
1002975.0,"Benzinga's Daily Biotech Pulse: Insmed Presents Data, Pfenex Pulls Back On Offering, Oncolytics Listing",2018-05-23 08:15:00-04:00,PFNX,neutral
1002976.0,"Pfenex Announces Offering of Common Stock, No Terms Disclosed",2018-05-22 16:23:00-04:00,PFNX,negative
1002977.0,45 Biggest Movers From Yesterday,2018-05-16 06:01:00-04:00,PFNX,neutral
1002978.0,37 Stocks Moving In Tuesday's Mid-Day Session,2018-05-15 12:32:00-04:00,PFNX,neutral
1002979.0,A Peek Into The Markets: US Stock Futures Down Ahead Of Economic Reports,2018-05-15 06:57:00-04:00,PFNX,neutral
1002980.0,"10 Stocks To Watch For May 15, 2018",2018-05-15 04:33:00-04:00,PFNX,neutral
1002981.0,48 Biggest Movers From Yesterday,2018-05-15 04:26:00-04:00,PFNX,neutral
1002982.0,10 Stocks Moving In Monday's After-Hours Session,2018-05-14 17:45:00-04:00,PFNX,neutral
1002983.0,UPDATE: Pfenex On PF708 Data: 'No imbalances in severity or incidence of adverse events',2018-05-14 17:00:00-04:00,PFNX,negative
1002984.0,"UPDATE: Pfenex Says PF708-301 Study Results Showed Comparable Overall Profiles Of PF708, Forteo",2018-05-14 16:59:00-04:00,PFNX,neutral
1002985.0,Pfenex Shares Up 19.3% After Hours Following Positive Top-Line PF708 Study Results In Osteoporosis Patients,2018-05-14 16:28:00-04:00,PFNX,positive
1002986.0,"Pfenex Shares Opened For Trade At 4:20 p.m. EDT; Not Yet Seeing Updated Last Price, But Shares Indicated Up 20%",2018-05-14 16:24:00-04:00,PFNX,positive
1002987.0,"Pfenex Announces Positive Top-Line PF708 Study Results In Osteoporosis Patients, On-Track For Submission Of New Drug Application In Third Quarter 2018",2018-05-14 16:21:00-04:00,PFNX,positive
1002988.0,Pfenex Shares Halted News Pending,2018-05-14 15:16:00-04:00,PFNX,positive
1002989.0,36 Stocks Moving In Monday's Mid-Day Session,2018-05-14 12:50:00-04:00,PFNX,neutral
1002990.0,"Pfenex Q1 EPS $(0.47) Misses $(0.43) Estimate, Sales $3.746M Miss $7.04M Estimate",2018-05-10 17:13:00-04:00,PFNX,negative
1002991.0,Pfenex and NT Pharma Enter Development and License Agreement For Pfenex's PF708 Therapeutic Equivalent to Forteo,2018-04-18 17:00:00-04:00,PFNX,positive
1002992.0,41 Biggest Movers From Yesterday,2018-04-03 04:18:00-04:00,PFNX,neutral
1002993.0,33 Stocks Moving In Monday's Mid-Day Session,2018-04-02 12:53:00-04:00,PFNX,neutral
1002994.0,"Pfenex Reports Q4 EPS $0.23 vs $(0.45) In Same Qtr. Last Year, Sales $17.909M vs $5.471M YoY",2018-03-15 16:43:00-04:00,PFNX,neutral
1002995.0,"Earnings Scheduled For March 15, 2018",2018-03-15 04:17:00-04:00,PFNX,neutral
1002996.0,Pfenex Names Susan Knudson CFO,2018-01-04 08:01:00-05:00,PFNX,neutral
1002997.0,46 Biggest Movers From Yesterday,2017-12-21 05:41:00-05:00,PFNX,neutral
1002998.0,45 Biggest Movers From Yesterday,2017-12-20 04:54:00-05:00,PFNX,neutral
1002999.0,Mid-Afternoon Market Update: NASDAQ Down 0.5%; China Recycling Energy Shares Spike Higher,2017-12-19 14:31:00-05:00,PFNX,positive
1003000.0,36 Stocks Moving In Tuesday's Mid-Day Session,2017-12-19 12:25:00-05:00,PFNX,neutral
1003001.0,Mid-Day Market Update: McDermott Drops Following Merger Deal With CB&I; Pfenex Shares Surge,2017-12-19 12:07:00-05:00,PFNX,positive
1003002.0,Mid-Morning Market Update: Markets Edge Lower; Darden Restaurants Tops Q2 Expectations,2017-12-19 10:13:00-05:00,PFNX,positive
1003003.0,"Pfenex Earns $18.5M In Milestones And Updates Worldwide License And Option Agreement With Jazz Pharmaceuticals; Under Amended Agreement, Pfenex Is Eligible To Receive An Additional $43.5M In Amendment Fee And Development Milestone Paymets vs 2016 Agreemen",2017-12-19 08:04:00-05:00,PFNX,positive
1003004.0,"Pfenex Reports Q3 EPS $(0.37) vs $(0.56) Est., Sales $5.02M vs $3.3M Est.",2017-11-09 16:25:00-05:00,PFNX,neutral
1003005.0,Pfenex CFO Paul Wagner Leaving Co. Effective Oct. 13; Chief Manufacturing Officer Steve Sandoval Also Leaving Effective Sept. 8,2017-09-07 17:54:00-04:00,PFNX,positive
1003006.0,"Pfenex Reports Q2 EPS $(0.52) vs $(0.49) Est., Sales $3.029M vs $3.1M Est.",2017-08-09 17:00:00-04:00,PFNX,neutral
1003007.0,Pfenex Names Eef Schimmelpennink CEO,2017-08-03 06:19:00-04:00,PFNX,neutral
1003008.0,"Pfenex Reports Q1 EPS $(0.43) vs $(0.55) Est., Sales $2.818M vs $3M Est.",2017-05-08 17:03:00-04:00,PFNX,neutral
1003009.0,"Pfenex Announces Retirement of Chair, William Rohn",2017-03-31 16:07:00-04:00,PFNX,neutral
1003010.0,"Pfenex Reports Q4 EPS $(0.45) vs $(0.66) Est., Sales $5.471M vs $3.23M Est.",2017-03-15 16:10:00-04:00,PFNX,neutral
1003011.0,6 Stocks Analysts Forecast The Largest Year-Over-Year Revenue Declines,2016-12-27 08:14:00-05:00,PFNX,neutral
1003012.0,"Pfenex Reports Q3 EPS $1.47 vs. Prior Year Quarter $(0.33), Rev. $48.82M vs. Prior Year Quarter 2.05M",2016-11-09 17:27:00-05:00,PFNX,neutral
1003013.0,A Peek Into The Markets: U.S. Stock Futures Signal Higher Start On Wall Street,2016-08-08 07:49:00-04:00,PFNX,neutral
1003014.0,"Pfenex Announces Positive Anthrax Vaccine Study Results, Shows Tolerable Safety And Significant Immunogenicity",2016-08-08 07:35:00-04:00,PFNX,positive
1003015.0,"Pfenex Reports Q2 EPS $(0.43) vs. Est. $(0.47), Rev. $3.135M vs. Est. $2.55M",2016-08-08 07:35:00-04:00,PFNX,neutral
1003016.0,Jazz Pharmaceuticals and Pfenex Enter into a Worldwide License and Option Agreement Related to Product Candidates in Early Development for Hematological Malignancies,2016-07-28 16:05:00-04:00,PFNX,positive
1003017.0,Pfenex Q1 EPS ($0.35) vs ($0.45) est Revenue $2.76M vs $2.35M est,2016-05-09 17:42:00-04:00,PFNX,neutral
1003018.0,"Pfenex Reports Q4 EPS $(0.37) vs. Est. $(0.59), Rev. $3.261M vs. Est. $2.56M",2016-03-10 16:06:00-05:00,PFNX,neutral
1003019.0,Benzinga's Top #PreMarket Losers,2015-12-16 08:21:00-05:00,PFNX,negative
1003020.0,"Pfenex Prices Offering of 600K Shares at $11.75/Share, All Shares Offered, Sold by Dow Chemical",2015-12-16 06:47:00-05:00,PFNX,positive
1003021.0,Pfenex Reports Offering of 600K Shares,2015-12-15 16:42:00-05:00,PFNX,positive
1003022.0,"Nemucore Medical Innovations and Pfenex Report Licensing Agreement To Manufacture Anti-Cancer Therapeutic NMI-8000, Biological Active Form Of MIS",2015-12-14 08:06:00-05:00,PFNX,positive
1003023.0,Pfenex Reports Q3 EPS $(0.33) Vs Est $(0.46(,2015-11-13 08:01:00-05:00,PFNX,neutral
1003024.0,"Earnings Scheduled For November 13, 2015",2015-11-13 04:42:00-05:00,PFNX,neutral
1003025.0,Pfenex Announces Appointment Of Dennis Fenton To Board Of Directors,2015-09-15 08:32:00-04:00,PFNX,neutral
1003026.0,Benzinga's Top Initiations,2015-09-14 09:57:00-04:00,PFNX,positive
1003027.0,Evercore ISI Group Initiates Coverage on Pfenex at Buy,2015-09-14 04:11:00-04:00,PFNX,neutral
1003028.0,"Evercore ISI Initiates Coverage on Pfenex at Buy, Announces $25.00 PT",2015-09-09 16:13:00-04:00,PFNX,neutral
1003029.0,The Coming Drug-Patent Cliff Is Pushing This Portfolio Up,2015-08-20 14:48:00-04:00,PFNX,neutral
1003030.0,10 Biotech Stocks With Catalysts Coming Soon,2015-08-20 12:19:00-04:00,PFNX,neutral
1003031.0,Pfenex Inc. Awarded HHS Contract Valued At Up To $143.5M For The Advanced Development Of Next Generation Anthrax Vaccine,2015-08-17 08:06:00-04:00,PFNX,positive
1003032.0,"Pfenex Reports Q2 EPS $(0.27) vs. Est. $(0.39), Rev. $2.3M vs. Est. $2.07M",2015-08-13 08:03:00-04:00,PFNX,neutral
1003033.0,"Pfenex Reports Q2 Sales $2.3M vs $2.1M Est., Loss of $0.27/Share vs Loss of $0.39/Share Est.",2015-08-13 07:46:00-04:00,PFNX,negative
1003034.0,Barclays: Pfenex Is Worth $28/Share,2015-05-18 07:29:00-04:00,PFNX,positive
1003035.0,"Barclays Initiates Coverage on Pfenex at Overweight, Announces $28.00 PT",2015-05-18 02:57:00-04:00,PFNX,negative
1003036.0,"Pfenex Reports Q1 Loss $0.29 Vs Est Loss $0.24, Sales $1.98M vs Est $2.10M",2015-05-14 08:01:00-04:00,PFNX,negative
1003037.0,Pfenex Announces Early HSR Clearance for Collaboration with Hospira,2015-03-23 09:03:00-04:00,PFNX,neutral
1003038.0,Pfenex Inc. In Development Pact For Macular Degeneration Drug,2015-02-10 12:07:00-05:00,PFNX,neutral
1003039.0,Morning Market Gainers,2015-02-10 09:49:00-05:00,PFNX,neutral
1003040.0,Pfenex Shares Rise 30% Premarket Following Announcement of Collaboration With Hospira,2015-02-10 09:22:00-05:00,PFNX,positive
1003041.0,"Pfenex, Hospira Announce Collaboration",2015-02-10 09:16:00-05:00,PFNX,neutral
1003042.0,"Stocks With Highly Elevated Volume Compared To Prior Trading Day: CR, HNRG, PFNX, MSI, FSC",2015-02-09 15:39:00-05:00,PFNX,neutral
1003043.0,"Pfenex Announces Active IND, Additional BARDA Funding For Recombinant Anthrax Vaccine Program, Px563L",2014-12-22 08:34:00-05:00,PFNX,positive
1003044.0,Pfenex And PATH Partner On Vaccines,2014-10-09 17:01:00-04:00,PFNX,neutral
1003045.0,"Mizuho Securities Initiates Coverage on Pfenex at Buy, Announces $12.00 PT",2014-08-18 06:34:00-04:00,PFNX,positive
1003046.0,William Blair Initiates Coverage on Pfenex at Outperform,2014-08-18 06:34:00-04:00,PFNX,neutral
1003047.0,"JMP Securities Initiates Coverage on Pfenex at Market Outperform, Announces $15.00 PT",2014-08-18 06:34:00-04:00,PFNX,positive
1003048.0,"Shares of Pfenex Open for Trade at $6/Share, IPO Priced at $6",2014-07-24 09:38:00-04:00,PFNX,positive
1003049.0,"IPO Lookout: Lots of Action This Week, But Is Anything A Worthwhile Investment?",2014-07-21 16:37:00-04:00,PFNX,positive
1003050.0,Waiting on 6 IPOs This Morning,2014-07-18 08:15:00-04:00,PFNX,neutral
1003051.0,Pfenex Expects 8.13M Share IPO to Price at $8.00/Share,2014-07-17 13:53:00-04:00,PFNX,positive
1003052.0,9 IPOs To Watch For This Week,2014-07-14 11:06:00-04:00,PFNX,neutral
1003053.0,Pfenex Expects 5M Share IPO to Price $12.00-$14.00/Share,2014-07-07 09:07:00-04:00,PFNX,positive
1003054.0,Pfenex Files for up to $74.75M IPO,2014-06-05 16:38:00-04:00,PFNX,neutral
